Description: Descriptionof the drug, purpose: dizziness, treatment and prevention of cerebral circulatory disorders, prevention of transient cerebral circulatory disorders, memory improvement, tinnitusInstructionsGeneral characteristicsThe type of drugis a medicinal productOrgans and systemsnervous systemPurposedizziness, treatment and prevention of cerebral circulatory disorders, prevention of transient cerebral circulatory disorders, memory improvement, tinnitusIndications for use- disorders of brain functions, including age-related, associated with impaired cerebral circulation, accompanied by attention disorders, memory impairment, decreased intellectual abilities, dizziness, tinnitus, headache;- disorders of peripheral blood circulation and microcirculation, accompanied by a feeling of cold in the extremities, pain when walking, painful cramps and heaviness in the legs, paresthesia;- disorders of the inner ear, manifested by dizziness, unsteady gait and tinnitus.Contraindications- hypersensitivity to the components of the drug;- decreased blood clotting;- erosive gastritis;- peptic ulcer of the stomach and duodenum in the acute stage;- acute disorders of cerebral circulation;- acute myocardial infarction;- children under the age of 18 (due to the lack of sufficient clinical data).CompositionPer capsule:active ingredient: ginkgo biloba extract dry, standardized with a content of flavonol glycosides 22.0-27.0% and terpene lactones 5.0-12.0% - 80.0 mg;auxiliary components: microcrystalline cellulose - 184.6 mg, calcium stearate - 2.7 mg, colloidal silicon dioxide - 2.7 mg;capsules are solid gelatin (capsule composition: titanium dioxide E 171 - 1.00%, iron oxide red E 172 - 0.50%, iron oxide black E 172 - 0.39%, iron oxide yellow E 172 - 0.27%, gelatin - up to 100%).Pharmacological actionImproves cerebral blood circulation and the supply of oxygen and glucose to the brain. It has a vasoregulatory effect mainly on the vessels of the brain. Improves blood flow, prevents platelet aggregation. Prevents the formation of free radicals.Pharmacological groupangioprotective agent of plant originRelease formcapsulesThe method of application / administrationis oralThe minimum age of useis from 18 yearsAdditionallyStorage conditionsStore at a temperature not exceeding 25 ° C.Keep out of reach of children.OverdoseCases of overdose of the drug have not been reported to date.In case of overdose, treatment is symptomatic.Use during pregnancy and lactationDue to the lack of sufficient clinical data, the use of the drug during pregnancy and breastfeeding is not recommended.Influence on the ability to drive vehicles and machineryDuring the period of taking the drug, care should be taken when performing potentially dangerous activities that require increased concentration and speed of psychomotor reactions (including driving vehicles, working with moving mechanisms).Special instructionsDo not exceed the recommended dosage of the drug.With the development of a hypersensitivity reaction, the use of the drug should be discontinued. Before surgery, it is necessary to inform the doctor about the use of the drug.If you often experience dizziness and tinnitus, you should consult a doctor. In case of sudden deterioration or loss of hearing, you should immediately consult a doctor.Patients with bleeding (hemorrhagic diathesis) and patients receiving anticoagulant therapy should consult a doctor before starting drug therapy.It is not recommended to take the drug together with ethanol.Against the background of the use of the drug in patients suffering from epilepsy, epileptic seizures may occur.Read completelyInteractionIt is not recommended to use the drug in patients who are constantly taking acetylsalicylic acid, anticoagulants (direct and indirect action), as well as drugs that reduce blood clotting.Registration numberLSR-001576/08 LP-005251 LP-002528 LP-No.(001853)-(RG-RU) LP-No.(001945)-(RG-RU) LP-No.(001997)-(RG-RU)Date of state registration06.12.2017 20.12.2018 09.07.2019 27.02.2023 14.03.2023 20.03.2023The owner of the registration certificateEvalarManufacturerEvalarPackerEvalarBrand CountryRussiaCountry of originRussiaName of the drugGinkumExpiration date972 days.
Price: 34.95 USD
Location: Porter Ranch, California
End Time: 2024-09-07T22:10:48.000Z
Shipping Cost: 0 USD
Product Images
Item Specifics
All returns accepted: ReturnsNotAccepted
Brand: Evalar
Herstellernummer: 4602242007012
Anzahl der Tabletten: 30
Marke: Evalar
Inhaltsstoffe: Ginkgo (Ginkgo biloba)
Produktart: Extrakt
Formulierung: Tablette
Nährwertkennzeichnung: Ja
Geschmack: Neutral
Wirksame Inhaltsstoffe: Ginkgo (Ginkgo biloba)
Hauptverwendungszweck: Allgemeines Wohlbefinden
